Atlas Trials

A Clinical Study Evaluating the Efficacy and Safety of SHR-1139 Injection in Adult Patients With Ulcerative Pyoderma Gangrenosum

Clinical trial NCT07337564 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07337564
Sponsor
Shandong First Medical University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Pyoderma Gangrenosum
Start date
2026-02-01
Primary completion
2027-12-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.